Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction Complicated by Cardiogenic Shock
https://doi.org/10.15360/1813-9779-2013-3-54
Abstract
Cardiogenic shock is one of the main causes of death in patients with acute myocardial infarction with the mortality rates being as high as 60—80%. Extracorporeal membrane oxygenation (ECMO) is a life-saving technique in patients with cardiogenic shock. Subjects and methods. Veno-arterial ECMO was connected and the coronary arteries were stented in a 53-year-old female patient with acute myocardial infarction complicated by severe cardiogenic shock refractory to drug therapy and intra-aortic counterpulsation (IACP). ECMO was maintained at a volumetric perfusion rate of 4.5 l/min (2.5 l/min/m2). The duration of ECMO was 138.5 hours (5.8 days); that of IACP was 9 days. In the first 24 hours, there were no ECMO-related complications apart from mild bleeding from the site of cannula insertion. The patient stayed in the intensive care unit 12 days. Results. IACP is used to treat cardiogenic shock, but it is ineffective in severe cardiogenic shock. ECMO is one of the possible options for maintaining life and for stabilizing the condition. Current ECMO systems may be employed for urgent peripheral connection and coronary artery intervention. ECMO may be used for resuscitation and temporary life support, which permits as high as 50—75% of patients with refractory cardiogenic shock to be saved. Conclusion: emergency coronary stenting with ECMO support is the technique of choice for the treatment of acute myocardial infarction complicated by severe cardiogenic shock. Key words: extracorporeal membrane oxygenation, cardiogenic shock, coronary artery stenting.
About the Authors
I. A. KornilovI. O. Grazhdankin
D. A., Redkin
M. N. Deryagin
S. M. Efremov
V. V. Lomivorotov
References
1. Мороз В.В., Лихванцев В.В., Гребенчиков О.А.Общая реаниматология.
2. Babaev A., Frederick P.D, Pasta DJ., Every N., Sichrovsky T., HochmanJ.S.; NRMI Investigators.Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.JAMA.2005; 294 (4): 448—454.
3. O’Gara P.T., Kushner F.G., Ascheim D.D., Casey D.EJr., Chung M.K., de Lemos JA., Ettinger SM., FangJ.C., Fesmire F.M., Franklin BA., Granger C.B., Krumholz H.M., Linderbaum J.A., Morrow D.A., Newby L.K., Ornato J.P., Ou N., Radford M.J., Tamis-Holland J.E., Tommaso C.L., Tracy C.M., Woo Y.J., Zhao DX., Anderson J.L., Jacobs A.K., Halperin J.L., Albert N.M., Brindis R.G., Creager M.A., De Mets D., Guyton R.A., Hochman J.S., Kovacs R.J., Kushner F.G., Ohman E.M., Stevenson W.G., Yancy C.W.; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Circulation.2013; 127 (4): e362—e425.
4. Sia S.K., Huang C.N., Ueng K.C., Wu Y.L., Chan K.C.Double vessel acute myocardial infarction showing simultaneous total occlusion of left anterior descending artery and right coronary artery.Circ. J.2008; 72 (6): 1034—1036.
5. Lee M.S., Pessegueiro A., Tobis J.The role of extracorporeal membrane oxygenation in emergent percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock and cardiac arrest.J. Invasive Cardiol.2008; 20 (9): E269—E272.
6. Shammas N.W., Roberts S., Early G.Extracorporeal membrane oxygena-tion for unprotected left main stenting in a patient with totally occluded right coronary artery and severe left ventricular dysfunction.J. Invasive Cardiol.2002; 14 (12): 756—759.
7. Dardas P., Mezilis N., Ninios V., Theofilogiannakos E.K., Tsikaderis D., Tsotsolis N., Kolettas A., Nikoloudakis N., Pitsis A.A.ECMO as a bridge to high-risk rotablation of heavily calcified coronary arteries.Herz.2012; 37 (2): 225—230.
8. Vainer J., van Ommen V., Maessen J., Geskes G., Lamerichs L., Waltenberger J.Elective high-risk percutaneous coronary interventions supported by extracorporeal life support.Am. J. Cardiol.2007; 99 (6): 771—773.
9. Dixon S.R., Henriques J.P., Mauri L., Sjauw K., Civitello A., Kar B., Loyalka P., Resnic F.S., Teirstein P., Makkar R., Palacios I.F., Collins M.,MosesJ., Benali K., O’Neill W.W.A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.JACC. Cardiovasc. Interv.2009; 2 (2): 91—96.
10. Westaby S., Anastasiadis K., Wieselthaler G.M.Cardiogenic shock in ACS. Part 2: role of mechanical circulatory support.Nat. Rev. Cardiol.2012; 9 (4): 195—208.
11. Chen Y.S., LinJ.W., Yu H.Y., Ko WJ.,Jerng J.S., Chang W.T., Chen WJ., Huang S.C., ChiN.H., Wang C.H., Chen L.C., TsaiP.R., WangS.S., HwangJJ., Lin F.Y.Cardiopulmonary resuscitation with assisted extracorporeal life support versus conventional cardiopulmonary resuscitation in adults with in hospital cardiac arrest: an observational study and propensity analysis.Lancet.2008; 372 (9638): 554—561.
12. Bakhtiary F., Keller H., Dogan S., Dzemali O., Oezaslan F., Meininger D., Ackermann H., Zwissler B., Kleine P., Moritz A.Venoarterial extracorpo-real membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients.J. Thorac. Cardiovasc. Surg.2008; 135 (2): 382—388.
Review
For citations:
Kornilov I.A., Grazhdankin I.O., Redkin D.A., Deryagin M.N., Efremov S.M., Lomivorotov V.V. Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction Complicated by Cardiogenic Shock . General Reanimatology. 2013;9(3):54. (In Russ.) https://doi.org/10.15360/1813-9779-2013-3-54
Views:
2031
Email this article 